Miteri Development Bank Limited
MDB
$359.38
+6.99%
MongoDB, Inc. is a leading provider of a modern, document-oriented database platform that accelerates application development, operating within the Software - Infrastructure industry. The company is a dominant disruptor in the database market, challenging legacy relational database vendors with its developer-friendly, flexible NoSQL approach, and its fully-managed cloud service, MongoDB Atlas, is its primary growth engine. The current investor narrative is intensely focused on the stock's dramatic volatility, swinging between fears of a 'SaaS apocalypse' and AI-driven selloffs to strong earnings-driven recoveries, as debates center on whether its high growth trajectory can be sustained against macroeconomic headwinds and competitive pressures.…
MDB
Miteri Development Bank Limited
$359.38
Related headlines
Investment Opinion: Should I buy MDB Today?
Rating & Thesis: Hold. MongoDB presents a compelling but high-risk growth story at a crossroads; investors should wait for clearer confirmation of sustained profitability and growth stabilization before committing new capital. The overwhelmingly bullish analyst sentiment (8 out of 10 Buy ratings) and recent upgrades suggest a constructive view, but the lack of a consensus price target in the data underscores the uncertainty.
Supporting Evidence: The hold rating is supported by four key data points: 1) The valuation, while compressed from its peak (PS of 12.25x vs. historical 43.42x), remains premium (forward PE of 40.08x). 2) Revenue growth is robust at 26.75% YoY but shows signs of sequential moderation. 3) Profitability is improving but fragile, with a Q4 operating margin of just 0.0072%. 4) The stellar balance sheet (current ratio 4.65, $508.5M FCF) and lack of debt provide a significant margin of safety against the operational volatility.
Risks & Conditions: The two biggest risks are a further deceleration in revenue growth below 20% and a return to consistent net losses. This Hold would upgrade to a Buy if the stock's PS ratio compresses further toward 10x while revenue growth holds above 25%, or if operating margins expand sustainably above 5%. It would downgrade to a Sell if revenue growth decelerates below 15% or if the stock breaks below its 52-week low of $198.47. Relative to its own hyper-growth history, the stock is fairly valued; relative to the market's current appetite for profitable growth, it remains slightly overvalued.
Sign up to view all
MDB 12-Month Price Forecast
MongoDB is a fundamentally strong company caught in a punishing market re-rating. The core Atlas growth engine and pristine balance sheet justify a long-term bullish view, but near-term headwinds from growth fears, profitability questions, and extreme volatility warrant caution. The neutral stance reflects this dichotomy: the risk/reward is balanced at current levels. The stance would upgrade to bullish on a confirmed breakout above $350 with volume, signaling the downtrend has broken. It would downgrade to bearish on a sustained break below $250, indicating the bear market remains in force.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Miteri Development Bank Limited's 12-month outlook, with a consensus price target around $467.19 and implied upside of +30.0% versus the current price.
Average Target
$467.19
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$288 - $467
Analyst target range
Analyst coverage for MongoDB appears limited in the provided data, with only 7 analysts cited for estimates, and no explicit consensus rating, average price target, or target range is available in the 'Analyst data' or 'Institutional ratings' sections. The data shows estimated revenue for the next period is $5.68 billion, with a range from $5.55B to $5.89B, but lacks corresponding price targets. Given the insufficient explicit target data, the institutional ratings provide the clearest sentiment signal. The recent ratings from March 2026 show a overwhelmingly bullish skew, with 8 out of 10 firms issuing Buy/Outperform/Overweight ratings, and only 2 (Mizuho, Macquarie) at Neutral. Notably, Mizuho upgraded from Neutral to Outperform, and Scotiabank upgraded from Sector Perform to Sector Outperform in March, indicating a positive shift in analyst sentiment following the Q4 earnings report. The lack of Sell ratings and the presence of upgrades suggest a constructive but cautious analyst view, with the wide dispersion in revenue estimates hinting at underlying uncertainty about the precise growth path.
Bulls vs Bears: MDB Investment Factors
The evidence presents a tense battle between robust fundamental health and severe technical/market sentiment damage. The bull case is stronger on a standalone fundamental basis, anchored by the Q4 profitability rebound, powerhouse cash flow, and a de-risked valuation. However, the bear case currently holds sway in the near term, as evidenced by the stock's deep downtrend, high volatility, and sensitivity to growth fears. The single most important tension is whether the company's 26.75% revenue growth and nascent profitability can stabilize and accelerate to justify its still-premium multiples, or if macro headwinds and competitive pressures will force a further growth deceleration and multiple compression.
Bullish
- Strong Q4 Profitability Rebound: MDB swung to a net income of $15.53 million in Q4 FY2026 from losses in the prior three quarters, demonstrating a critical inflection towards profitability. This was driven by robust 26.75% YoY revenue growth to $695.07 million, indicating the core business remains highly scalable.
- Exceptional Balance Sheet & Cash Flow: The company boasts a fortress balance sheet with a current ratio of 4.65, minimal debt (D/E of 0.011), and $1.09 billion in cash. Most importantly, it generates substantial free cash flow ($508.51M TTM), providing immense financial flexibility to invest through cycles without dilution risk.
- Dominant Atlas Growth Engine: MongoDB Atlas, its cloud platform, generated $941.57 million in revenue, over three times the revenue from other subscriptions ($303.88M). This structural shift to a high-margin, recurring cloud service underpins the long-term growth narrative and gross margins of 73.04%.
- Valuation Compression from Peak: The stock's trailing PS ratio has compressed dramatically to 12.25x from a historical high of 43.42x, representing a significant de-rating. This suggests much of the hyper-growth premium has been washed out, potentially creating a more reasonable entry point for a still-growing business.
Bearish
- Severe Technical Downtrend & Volatility: The stock is down 33.9% from its 52-week high and has suffered a -32.52% 6-month drawdown, trading near 66% of its 52-week range. Its high beta of 1.55 indicates 55% more volatility than the market, leading to amplified losses during risk-off periods.
- Inconsistent Operating Profitability: Despite a positive net income in Q4, operating income was a razor-thin $0.05 million, resulting in an operating margin of just 0.0072%. The trailing operating margin is -5.56%, highlighting ongoing challenges in converting high revenue growth into sustainable operating profits.
- Growth Deceleration Concerns: While Q4 revenue grew 26.75% YoY, the sequential quarterly growth from Q1 to Q4 FY2026 shows a pattern of moderation. Recent news highlights investor focus on a 'slowing growth outlook,' which could pressure the premium valuation further if sustained.
- Premium Valuation Despite Compression: Even after significant compression, a trailing PS of 12.25x and a forward PE of 40.08x remain at a premium, demanding sustained high growth. The PEG ratio of 8.59 is extremely high, signaling the market prices in exceptional future growth that may be at risk.
MDB Technical Analysis
The stock is in a pronounced downtrend from its recent highs, trading at $294.10, which represents a 33.9% decline from its 52-week high of $444.72 and positions it at approximately 66% of its 52-week range ($198.47 to $444.72). Despite a positive 1-year return of 42.24%, the stock has suffered a severe 6-month drawdown of -32.52% and a year-to-date decline of -26.41%, indicating significant recent pressure and a breakdown from previous highs. Recent momentum shows conflicting signals: the stock has gained 24.88% over the last 3 months, suggesting a potential recovery attempt, but it is down -4.31% over the past month, indicating this recovery may be stalling or encountering resistance amidst broader market weakness, as evidenced by its -2.14 relative strength versus the SPY over the same period. Key technical support is at the 52-week low of $198.47, while immediate resistance is at the 52-week high of $444.72. A sustained breakdown below the $198.47 support would signal a continuation of the bearish trend and potentially target lower levels, whereas a breakout above $444.72 would invalidate the downtrend and suggest a resumption of the longer-term bull market. The stock's beta of 1.55 indicates it is 55% more volatile than the broader market, which explains its amplified moves and necessitates larger risk buffers for investors; this high volatility is corroborated by the maximum drawdown of -48.72% observed in the provided price data.
Beta
1.55
1.55x market volatility
Max Drawdown
-48.7%
Largest decline past year
52-Week Range
$198-$445
Price range past year
Annual Return
+74.4%
Cumulative gain past year
| Period | MDB Return | S&P 500 |
|---|---|---|
| 1m | -11.0% | -1.7% |
| 3m | +42.0% | +13.7% |
| 6m | -10.1% | +9.2% |
| 1y | +74.4% | +20.7% |
| ytd | -10.1% | +9.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MDB Fundamental Analysis
Revenue growth remains robust but shows signs of sequential deceleration. The most recent quarterly revenue (Q4 FY2026) was $695.07 million, representing a strong 26.75% year-over-year growth. However, examining the quarterly sequence from Q1 to Q4 FY2026 ($549.01M, $591.40M, $628.31M, $695.07M) reveals that while absolute revenue is climbing, the quarter-over-quarter growth rates have moderated. The business is heavily driven by its cloud platform, MongoDB Atlas, which generated $941.57 million in revenue, significantly outpacing the $303.88 million from other subscriptions. Profitability is inconsistent but showed a notable improvement in the latest quarter. The company reported net income of $15.53 million for Q4 FY2026, a positive swing from losses in the preceding three quarters (Q1: -$37.63M, Q2: -$47.05M, Q3: -$2.01M). Gross margin remains exceptionally high at 73.04% for the quarter, consistent with its software business model, but operating margins are thin, with Q4 operating income at just $0.05 million, resulting in an operating margin of 0.0072%. The balance sheet is strong with ample liquidity and manageable debt. The company boasts a robust current ratio of 4.65 and a very low debt-to-equity ratio of 0.011. Most importantly, MongoDB generates substantial free cash flow, with trailing twelve-month free cash flow of $508.51 million. This strong cash generation, coupled with $1.09 billion in cash at the end of Q4, provides significant financial flexibility to fund growth initiatives and weather potential downturns without relying on external financing.
Quarterly Revenue
$695072000.0B
2026-01
Revenue YoY Growth
+0.26%
YoY Comparison
Gross Margin
+0.73%
Latest Quarter
Free Cash Flow
$508509000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MDB Overvalued?
Given the company's inconsistent profitability (net income of $15.53M in the latest quarter but negative trailing EPS of -$0.002), the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 12.25x, while the forward-looking metric, EV-to-Sales, is 8.44x. The lower forward multiple suggests the market is pricing in continued revenue growth, expecting sales to expand into the current valuation. Compared to industry averages, data is not available in the provided dataset for a direct sector PS or EV/Sales comparison. Therefore, a peer comparison cannot be quantified. The valuation must be assessed based on the company's own growth profile and historical context. Historically, MongoDB's valuation has compressed significantly from its peak. The current PS ratio of 12.25x is far below its historical highs seen in recent years, such as the PS ratio of 43.42x recorded at the end of Q4 FY2026 (Jan 2026) according to the historical ratios data. This dramatic de-rating suggests the market has shifted from pricing in hyper-growth expectations to a more normalized, albeit still premium, growth valuation, reflecting concerns about growth sustainability and profitability.
PE
-422.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -3641x~486x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-993.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: MongoDB's primary financial risk is its inconsistent path to operating profitability. Despite a net income of $15.53 million in Q4, operating income was a negligible $50,000, and the trailing operating margin is -5.56%. The company remains heavily reliant on continued high revenue growth (26.75% YoY in Q4) to cover substantial operating expenses, particularly Sales & Marketing ($248.5M in Q4) and R&D ($189.1M). A deceleration in this growth, as hinted by sequential quarterly trends, would quickly expose the thin operating margin and could return the company to net losses.
Market & Competitive Risks: The stock faces acute valuation compression risk, trading at a trailing PS of 12.25x and a forward PE of 40.08x, which are high multiples dependent on flawless execution. Its beta of 1.55 makes it 55% more volatile than the market, amplifying losses during sector rotations or risk-off periods, as seen in the recent -48.72% maximum drawdown. Competitive risks are inherent as legacy database vendors and cloud hyperscalers intensify competition in the data platform space, potentially pressuring pricing and growth for MongoDB Atlas.
Worst-Case Scenario: The worst-case scenario involves a combination of a severe economic downturn curbing enterprise IT spend, a competitive product launch eroding Atlas's market share, and consecutive quarters of missed revenue estimates. This could trigger a full-scale derating, pushing the valuation toward its 52-week low support of $198.47. From the current price of $294.10, this represents a realistic downside of approximately -32.5%. A breach of this level could see the stock test even lower prices, mirroring the extreme volatility captured in its historical price data.
FAQ
The key risks are: 1) Growth Deceleration Risk: Revenue growth, while strong at 26.75%, shows signs of sequential moderation; a drop below 20% would crush the valuation. 2) Profitability Risk: Operating margins are razor-thin (0.0072% in Q4); the company has not proven it can consistently generate operating profits. 3) Valuation & Volatility Risk: With a beta of 1.55, the stock is 55% more volatile than the market, leading to amplified drawdowns (max -48.72%). 4) Competitive Risk: Intense competition from cloud giants and legacy vendors could pressure pricing and market share for MongoDB Atlas.
Our 12-month forecast outlines three scenarios. The Base Case (50% probability) sees the stock trading between $300 and $350, assuming growth stabilizes in the mid-20% range. The Bull Case (30% probability) targets $400 to $444 (52-week high) on re-accelerating growth and multiple expansion. The Bear Case (20% probability) warns of a retest of the 52-week low, with a range of $198 to $250, triggered by growth deceleration and sustained losses. The Base Case is most likely, hinging on the assumption that macroeconomic conditions do not worsen significantly.
MDB is fairly valued relative to its current growth profile but remains expensive on an absolute basis. Its trailing Price-to-Sales ratio of 12.25x is a significant discount to its historical peak of 43.42x, indicating a major de-rating. However, a forward PE of 40.08x and a PEG ratio of 8.59 are very high, implying the market still expects exceptional future growth. Compared to unprofitable hyper-growth stories, it may be fairly valued; compared to profitable software companies, it is overvalued. The valuation implies the market expects sustained ~25% growth and a rapid path to consistent profitability.
MDB is a speculative buy only for investors with high risk tolerance and a long-term view. The company has strong fundamentals, including 26.75% revenue growth, $508.5 million in annual free cash flow, and a rock-solid balance sheet. However, the stock is in a severe downtrend, down 33.9% from its high, and trades at premium valuations (forward PE of 40.08x) that demand flawless execution. It could be a good buy for those believing the growth story remains intact and who can stomach potential further volatility toward the $198 support level.
MDB is strictly suitable for long-term investment (minimum 3-5 year horizon). Its high beta of 1.55 and history of severe drawdowns (-48.72%) make it a poor candidate for short-term trading, as sentiment and macro factors can cause violent swings unrelated to fundamentals. Long-term investors can potentially benefit from the secular shift to cloud databases, but must be prepared to endure significant volatility. The lack of a dividend further emphasizes its role as a pure capital appreciation vehicle, which requires time for the growth story to fully play out.